Comprehensive liquid biopsy analysis for monitoring NSCLC patients under second-line osimertinib treatment
Multi-marker analysis of circulating tumor cells in localized intermediate/high-risk and metastatic prostate cancer
Low‑pass whole genome sequencing of circulating tumor cells to evaluate chromosomal instability in triple‑negative breast cancer
Identification of circulating tumor cells captured by the FDA-cleared Parsortix® PC1 system from the peripheral blood of metastatic breast cancer patients using immunofluorescence and cytopathological evaluations
Gene expression markers in peripheral blood and outcome in patients with platinum-resistant ovarian cancer: A study of the European GANNET53 consortium
Targeting Translation and the Cell Cycle Inversely Affects CTC Metabolism but Not Metastasis
DanioCTC: Analysis of Circulating Tumor Cells from Metastatic Breast Cancer Patients in Zebrafish Xenografts
Feasibility of mass cytometry proteomic characterisation of circulating tumour cells in head and neck squamous cell carcinoma for deep phenotyping
Analytical performance of the FDA-cleared Parsortix®PC1 system
Association of Circulating Tumor Cells, Megakaryocytes and a High Immune-Inflammatory Environment in Metastatic Breast Cancer